DRAXIMAGE, Inc. Sustainability Profile
DRAXIMAGE, Inc., headquartered in California, is a leading player in the medical imaging industry, specialising in the development and distribution of radiopharmaceuticals. Founded in 2004, the company has established a strong presence in North America and beyond, focusing on innovative solutions for diagnostic imaging and therapeutic applications. With a commitment to quality and safety, DRAXIMAGE offers a range of core products, including radiopharmaceuticals for nuclear medicine, which are distinguished by their high purity and efficacy. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. Recognised for its dedication to advancing healthcare, DRAXIMAGE continues to contribute to the evolving landscape of medical imaging, ensuring better patient outcomes through cutting-edge technology.
DitchCarbon Score
How does DRAXIMAGE, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
DRAXIMAGE, Inc.'s score of 32 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
DRAXIMAGE, Inc., headquartered in California, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Jubilant Pharmova Limited, which may influence its climate commitments and performance metrics. As part of its corporate family, DRAXIMAGE may inherit sustainability initiatives and targets from Jubilant Pharmova Limited. However, specific reduction targets or achievements related to carbon emissions have not been disclosed. The absence of documented reduction initiatives or commitments suggests that DRAXIMAGE is still in the process of establishing its climate strategy. In the context of the industry, it is essential for companies like DRAXIMAGE to align with global climate standards and frameworks, such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), to enhance transparency and accountability in their environmental impact. As the company develops its climate commitments, it will be crucial to monitor any future announcements regarding emissions data and sustainability initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2015 | 2016 | 2017 | 2019 | 2020 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 894,456,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 107,906,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 12,057,000 | - | - | - | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is DRAXIMAGE, Inc.'s Industry?
How Carbon Intensive is DRAXIMAGE, Inc.'s Location?
DRAXIMAGE, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
DRAXIMAGE, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
